18 0 2 0 2 B-lower_bound
to 3 5 3 5 O
74 6 8 6 8 B-upper_bound
years 9 14 9 14 I-upper_bound
old 15 18 15 18 O

Had 0 3 19 22 O
major 4 9 23 28 B-treatment
surgery 10 17 29 36 I-treatment
within 18 24 37 43 O
4 25 26 44 45 B-upper_bound
weeks 27 32 46 51 I-upper_bound
prior 33 38 52 57 I-upper_bound
to 39 41 58 60 O
study 42 47 61 66 O
drug 48 52 67 71 O
treatment 53 62 72 81 B-treatment

Has 0 3 82 85 O
a 4 5 86 87 O
concomitant 6 17 88 99 O
medical 18 25 100 107 B-chronic_disease
condition 26 35 108 117 I-chronic_disease
that 36 40 118 122 O
would 41 46 123 128 O
increase 47 55 129 137 O
the 56 59 138 141 O
risk 60 64 142 146 O
of 65 67 147 149 O
toxicity 68 76 150 158 O

Has 0 3 159 162 O
a 4 5 163 164 O
diagnosis 6 15 165 174 O
of 16 18 175 177 O
acute 19 24 178 183 B-cancer
promyelocytic 25 38 184 197 I-cancer
leukemia 39 47 198 206 I-cancer

Has 0 3 207 210 O
a 4 5 211 212 O
diagnosis 6 15 213 222 O
of 16 18 223 225 O
refractory 19 29 226 236 B-cancer
or 30 32 237 239 I-cancer
relapsed 33 41 240 248 I-cancer
AML 42 45 249 252 I-cancer
or 46 48 253 255 O
high 49 53 256 260 O
risk 54 58 261 265 O
MDS 59 62 266 269 B-chronic_disease
for 63 66 270 273 O
inclusion 67 76 274 283 O
in 77 79 284 286 O
Part 80 84 287 291 O
1 85 86 292 293 O
, 86 87 293 294 O
Part 88 92 295 299 O
1A 93 95 300 302 O
, 95 96 302 303 O
and 97 100 304 307 O
Part 101 105 308 312 O
2 106 107 313 314 O
( 108 109 315 316 O
Cohorts 109 116 316 323 O
1 117 118 324 325 O
and 119 122 326 329 O
3 123 124 330 331 O
) 124 125 331 332 O

Has 0 3 333 336 O
a 4 5 337 338 O
life 6 10 339 343 B-clinical_variable
expectancy 11 21 344 354 I-clinical_variable
of 22 24 355 357 O
at 25 27 358 360 O
least 28 33 361 366 O
3 34 35 367 368 B-lower_bound
months 36 42 369 375 I-lower_bound

Has 0 3 376 379 O
a 4 5 380 381 O
malignancy 6 16 382 392 B-cancer
that 17 21 393 397 O
is 22 24 398 400 O
known 25 30 401 406 O
to 31 33 407 409 O
contain 34 41 410 417 O
a 42 43 418 419 O
non 44 47 420 423 O
synonymous 48 58 424 434 O
mutation 59 67 435 443 O
, 67 68 443 444 O
insertion 69 78 445 454 O
, 78 79 454 455 O
or 80 82 456 458 O
deletion 83 91 459 467 O
in 92 94 468 470 O
the 95 98 471 474 O
TP53 99 103 475 479 O
gene 104 108 480 484 O
determined 109 119 485 495 O
previously 120 130 496 506 O
or 131 133 507 509 O
at 134 136 510 512 O
screening 137 146 513 522 O

Has 0 3 523 526 O
a 4 5 527 528 O
second 6 12 529 535 O
concurrent 13 23 536 546 O
primary 24 31 547 554 B-cancer
malignancy 32 42 555 565 I-cancer
that 43 47 566 570 O
required 48 56 571 579 O
active 57 63 580 586 B-treatment
treatment 64 73 587 596 I-treatment
within 74 80 597 603 O
the 81 84 604 607 O
previous 85 93 608 616 B-upper_bound
2 94 95 617 618 I-upper_bound
years 96 101 619 624 I-upper_bound
, 101 102 624 625 O
except 103 109 626 632 O
for 110 113 633 636 O
localized 114 123 637 646 O
cancers 124 131 647 654 B-cancer
that 132 136 655 659 O
have 137 141 660 664 O
apparently 142 152 665 675 O
been 153 157 676 680 O
cured 158 163 681 686 O
, 163 164 686 687 O
such 165 169 688 692 O
as 170 172 693 695 O
non 173 176 696 699 B-cancer
- 176 177 699 700 I-cancer
melanoma 177 185 700 708 I-cancer
skin 186 190 709 713 I-cancer
cancer 191 197 714 720 I-cancer
, 197 198 720 721 O
superficial 199 210 722 733 B-cancer
bladder 211 218 734 741 I-cancer
cancer 219 225 742 748 I-cancer
, 225 226 748 749 O
or 227 229 750 752 O
carcinoma 230 239 753 762 B-cancer
in 240 242 763 765 I-cancer
situ 243 247 766 770 I-cancer
of 248 250 771 773 O
the 251 254 774 777 O
cervix 255 261 778 784 O
or 262 264 785 787 O
breast 265 271 788 794 O

Has 0 3 795 798 O
an 4 6 799 801 O
Eastern 7 14 802 809 B-clinical_variable
Cooperative 15 26 810 821 I-clinical_variable
Oncology 27 35 822 830 I-clinical_variable
Group 36 41 831 836 I-clinical_variable
( 42 43 837 838 I-clinical_variable
ECOG 43 47 838 842 I-clinical_variable
) 47 48 842 843 I-clinical_variable
performance 49 60 844 855 I-clinical_variable
status 61 67 856 862 I-clinical_variable
0 68 69 863 864 B-lower_bound
to 70 72 865 867 O
2 73 74 868 869 B-upper_bound

Has 0 3 870 873 O
an 4 6 874 876 O
uncontrolled 7 19 877 889 B-chronic_disease
infection 20 29 890 899 I-chronic_disease
requiring 30 39 900 909 O
IV 40 42 910 912 B-treatment
antibiotics 43 54 913 924 I-treatment
, 54 55 924 925 O
antivirals 56 66 926 936 B-treatment
, 66 67 936 937 O
or 68 70 938 940 O
antifungals 71 82 941 952 B-treatment
, 82 83 952 953 O
known 84 89 954 959 O
human 90 95 960 965 B-chronic_disease
immunodeficiency 96 112 966 982 I-chronic_disease
virus 113 118 983 988 I-chronic_disease
infection 119 128 989 998 I-chronic_disease
, 128 129 998 999 O
or 130 132 1000 1002 O
active 133 139 1003 1009 O
hepatitis 140 149 1010 1019 B-chronic_disease
B 150 151 1020 1021 I-chronic_disease
or 152 154 1022 1024 I-chronic_disease
C 155 156 1025 1026 I-chronic_disease
infection 157 166 1027 1036 I-chronic_disease

Has 0 3 1037 1040 O
any 4 7 1041 1044 O
condition 8 17 1045 1054 O
that 18 22 1055 1059 O
would 23 28 1060 1065 O
preclude 29 37 1066 1074 O
adequate 38 46 1075 1083 O
absorption 47 57 1084 1094 O
of 58 60 1095 1097 O
DS-3032b 61 69 1098 1106 O
, 69 70 1106 1107 O
including 71 80 1108 1117 O
refractory 81 91 1118 1128 O
nausea 92 98 1129 1135 B-chronic_disease
and 99 102 1136 1139 O
vomiting 103 111 1140 1148 B-chronic_disease
, 111 112 1148 1149 O
malabsorption 113 126 1150 1163 B-chronic_disease
, 126 127 1163 1164 O
biliary 128 135 1165 1172 O
shunt 136 141 1173 1178 O
, 141 142 1178 1179 O
significant 143 154 1180 1191 O
bowel 155 160 1192 1197 B-treatment
resection 161 170 1198 1207 I-treatment
, 170 171 1207 1208 O
and/or 172 178 1209 1215 O
graft 179 184 1216 1221 B-chronic_disease
- 184 185 1221 1222 I-chronic_disease
versus 185 191 1222 1228 I-chronic_disease
- 191 192 1228 1229 I-chronic_disease
host 192 196 1229 1233 I-chronic_disease
disease 197 204 1234 1241 I-chronic_disease
( 205 206 1242 1243 I-chronic_disease
GVHD 206 210 1243 1247 I-chronic_disease
) 210 211 1247 1248 I-chronic_disease
affecting 212 221 1249 1258 O
the 222 225 1259 1262 O
gut 226 229 1263 1266 O

Has 0 3 1267 1270 O
presence 4 12 1271 1279 O
of 13 15 1280 1282 O
central 16 23 1283 1290 O
nervous 24 31 1291 1298 O
system 32 38 1299 1305 O
( 39 40 1306 1307 O
CNS 40 43 1307 1310 O
) 43 44 1310 1311 O
involvement 45 56 1312 1323 O
of 57 59 1324 1326 O
leukemia 60 68 1327 1335 B-cancer
or 69 71 1336 1338 O
a 72 73 1339 1340 O
history 74 81 1341 1348 O
of 82 84 1349 1351 O
primary 85 92 1352 1359 O
CNS 93 96 1360 1363 B-cancer
leukemia 97 105 1364 1372 I-cancer

Has 0 3 1373 1376 O
prolongation 4 16 1377 1389 O
of 17 19 1390 1392 O
corrected 20 29 1393 1402 O
QT 30 32 1403 1405 B-clinical_variable
interval 33 41 1406 1414 I-clinical_variable
using 42 47 1415 1420 O
Fridericia 48 58 1421 1431 O
's 58 60 1431 1433 O
method 61 67 1434 1440 O
( 68 69 1441 1442 O
QTcF 69 73 1442 1446 O
) 73 74 1446 1447 O
at 75 77 1448 1450 O
rest 78 82 1451 1455 O
, 82 83 1455 1456 O
where 84 89 1457 1462 O
the 90 93 1463 1466 O
mean 94 98 1467 1471 O
QTcF 99 103 1472 1476 B-clinical_variable
interval 104 112 1477 1485 I-clinical_variable
is 113 115 1486 1488 O
> 116 117 1489 1490 O
450 118 121 1491 1494 B-lower_bound
ms 122 124 1495 1497 I-lower_bound
for 125 128 1498 1501 O
males 129 134 1502 1507 B-gender
or 135 137 1508 1510 O
> 138 139 1511 1512 O
470 140 143 1513 1516 B-lower_bound
ms 144 146 1517 1519 I-lower_bound
for 147 150 1520 1523 O
females 151 158 1524 1531 B-gender
based 159 164 1532 1537 O
on 165 167 1538 1540 O
triplicate 168 178 1541 1551 O
electrocardiograms 179 197 1552 1570 B-treatment
( 198 199 1571 1572 I-treatment
ECGs 199 203 1572 1576 I-treatment
) 203 204 1576 1577 I-treatment

Has 0 3 1578 1581 O
received 4 12 1582 1590 O
Hematopoietic 13 26 1591 1604 B-treatment
Stem 27 31 1605 1609 I-treatment
Cell 32 36 1610 1614 I-treatment
Transplantation 37 52 1615 1630 I-treatment
( 53 54 1631 1632 I-treatment
HSCT 54 58 1632 1636 I-treatment
) 58 59 1636 1637 I-treatment
within 60 66 1638 1644 O
60 67 69 1645 1647 B-upper_bound
days 70 74 1648 1652 I-upper_bound
of 75 77 1653 1655 O
the 78 81 1656 1659 O
first 82 87 1660 1665 O
dose 88 92 1666 1670 O
of 93 95 1671 1673 O
DS-3032b 96 104 1674 1682 B-treatment
, 104 105 1682 1683 O
is 106 108 1684 1686 O
on 109 111 1687 1689 O
immunosuppressive 112 129 1690 1707 B-treatment
therapy 130 137 1708 1715 I-treatment
post 138 142 1716 1720 I-treatment
- 142 143 1720 1721 I-treatment
HSCT 143 147 1721 1725 I-treatment
at 148 150 1726 1728 O
the 151 154 1729 1732 O
time 155 159 1733 1737 O
of 160 162 1738 1740 O
screening 163 172 1741 1750 O
, 172 173 1750 1751 O
or 174 176 1752 1754 O
has 177 180 1755 1758 O
clinically 181 191 1759 1769 O
significant 192 203 1770 1781 O
GVHD 204 208 1782 1786 B-chronic_disease
( 209 210 1787 1788 O
use 210 213 1788 1791 O
of 214 216 1792 1794 O
topical 217 224 1795 1802 B-treatment
steroids 225 233 1803 1811 I-treatment
for 234 237 1812 1815 O
ongoing 238 245 1816 1823 O
skin 246 250 1824 1828 O
GVHD 251 255 1829 1833 O
will 256 260 1834 1838 O
be 261 263 1839 1841 O
permitted 264 273 1842 1851 O
) 273 274 1851 1852 O
. 274 275 1852 1853 O
Has 276 279 1854 1857 O
a 280 281 1858 1859 O
washout 282 289 1860 1867 O
period 290 296 1868 1874 O
of 297 299 1875 1877 O
â‰¥ 300 301 1878 1879 O
2 302 303 1880 1881 B-lower_bound
weeks 304 309 1882 1887 I-lower_bound
or 310 312 1888 1890 O
at 313 315 1891 1893 O
least 316 321 1894 1899 O
4 322 323 1900 1901 B-lower_bound
half 324 328 1902 1906 I-lower_bound
- 328 329 1906 1907 I-lower_bound
lives 329 334 1907 1912 I-lower_bound
( 335 336 1913 1914 O
whichever 336 345 1914 1923 O
is 346 348 1924 1926 O
longer 349 355 1927 1933 O
) 355 356 1933 1934 O
from 357 361 1935 1939 O
their 362 367 1940 1945 O
last 368 372 1946 1950 O
systemic 373 381 1951 1959 B-treatment
immunosuppressive 382 399 1960 1977 I-treatment
treatment 400 409 1978 1987 I-treatment
for 410 413 1988 1991 O
GVHD 414 418 1992 1996 O

Has 0 3 1997 2000 O
unresolved 4 14 2001 2011 O
toxicities 15 25 2012 2022 O
from 26 30 2023 2027 O
previous 31 39 2028 2036 O
anticancer 40 50 2037 2047 B-treatment
therapy 51 58 2048 2055 I-treatment
, 58 59 2055 2056 O
defined 60 67 2057 2064 O
as 68 70 2065 2067 O
toxicities 71 81 2068 2078 O
( 82 83 2079 2080 O
other 83 88 2080 2085 O
than 89 93 2086 2090 O
alopecia 94 102 2091 2099 B-chronic_disease
) 102 103 2099 2100 O
not 104 107 2101 2104 O
yet 108 111 2105 2108 O
resolved 112 120 2109 2117 O
to 121 123 2118 2120 O
NCI 124 127 2121 2124 B-clinical_variable
- 127 128 2124 2125 I-clinical_variable
CTCAE 128 133 2125 2130 I-clinical_variable
Grade 134 139 2131 2136 I-clinical_variable
â‰¤ 140 141 2137 2138 O
1 142 143 2139 2140 B-upper_bound
, 143 144 2140 2141 O
or 145 147 2142 2144 O
baseline 148 156 2145 2153 O
. 156 157 2153 2154 O
Subjects 158 166 2155 2163 O
with 167 171 2164 2168 O
chronic 172 179 2169 2176 O
Grade 180 185 2177 2182 O
2 186 187 2183 2184 O
toxicities 188 198 2185 2195 O
may 199 202 2196 2199 O
be 203 205 2200 2202 O
eligible 206 214 2203 2211 O
at 215 217 2212 2214 O
the 218 221 2215 2218 O
discretion 222 232 2219 2229 O
of 233 235 2230 2232 O
the 236 239 2233 2236 O
Investigator 240 252 2237 2249 O
and 253 256 2250 2253 O
Sponsor 257 264 2254 2261 O
( 265 266 2262 2263 O
eg 266 268 2263 2265 O
, 268 269 2265 2266 O
Grade 270 275 2267 2272 O
2 276 277 2273 2274 O
chemotherapy 278 290 2275 2287 O
- 290 291 2287 2288 O
induced 291 298 2288 2295 O
neuropathy 299 309 2296 2306 O
) 309 310 2306 2307 O

Is 0 2 2308 2310 O
able 3 7 2311 2315 O
and 8 11 2316 2319 O
willing 12 19 2320 2327 O
to 20 22 2328 2330 O
provide 23 30 2331 2338 O
bone 31 35 2339 2343 O
marrow 36 42 2344 2350 B-treatment
biopsies 43 51 2351 2359 I-treatment
/ 51 52 2359 2360 I-treatment
aspirates 52 61 2360 2369 I-treatment
as 62 64 2370 2372 O
requested 65 74 2373 2382 O
by 75 77 2383 2385 O
the 78 81 2386 2389 O
protocol 82 90 2390 2398 O

Is 0 2 2399 2401 O
able 3 7 2402 2406 O
to 8 10 2407 2409 O
provide 11 18 2410 2417 O
written 19 26 2418 2425 O
informed 27 35 2426 2434 O
consent 36 43 2435 2442 O
( 44 45 2443 2444 O
or 45 47 2444 2446 O
authorized 48 58 2447 2457 O
representative 59 73 2458 2472 O
) 73 74 2472 2473 O
, 74 75 2473 2474 O
comply 76 82 2475 2481 O
with 83 87 2482 2486 O
protocol 88 96 2487 2495 O
visits 97 103 2496 2502 O
and 104 107 2503 2506 O
procedures 108 118 2507 2517 O
, 118 119 2517 2518 O
and 120 123 2519 2522 O
take 124 128 2523 2527 O
oral 129 133 2528 2532 B-treatment
medication 134 144 2533 2543 I-treatment
, 144 145 2543 2544 O
and 146 149 2545 2548 O
does 150 154 2549 2553 O
not 155 158 2554 2557 O
have 159 163 2558 2562 O
any 164 167 2563 2566 O
active 168 174 2567 2573 B-chronic_disease
infection 175 184 2574 2583 I-chronic_disease
or 185 187 2584 2586 O
comorbidity 188 199 2587 2598 O
that 200 204 2599 2603 O
would 205 210 2604 2609 O
interfere 211 220 2610 2619 O
with 221 225 2620 2624 O
therapy 226 233 2625 2632 B-treatment

Is 0 2 2633 2635 O
willing 3 10 2636 2643 O
to 11 13 2644 2646 O
undergo 14 21 2647 2654 O
malignancy 22 32 2655 2665 B-treatment
genotyping 33 43 2666 2676 I-treatment
for 44 47 2677 2680 O
TP53 48 52 2681 2685 O
mutation 53 61 2686 2694 O
, 61 62 2694 2695 O
insertion 63 72 2696 2705 O
, 72 73 2705 2706 O
or 74 76 2707 2709 O
deletion 77 85 2710 2718 O
at 86 88 2719 2721 O
screening 89 98 2722 2731 O

Is 0 2 2732 2734 O
â‰¥ 3 4 2735 2736 O
75 5 7 2737 2739 B-lower_bound
years 8 13 2740 2745 I-lower_bound
of 14 16 2746 2748 O
age 17 20 2749 2752 B-age
with 21 25 2753 2757 O
ECOG 26 30 2758 2762 B-clinical_variable
performance 31 42 2763 2774 I-clinical_variable
status 43 49 2775 2781 I-clinical_variable
0 50 51 2782 2783 B-lower_bound
to 52 54 2784 2786 O
2 55 56 2787 2788 B-upper_bound

Other 0 5 2789 2794 O
criteria 6 14 2795 2803 O
for 15 18 2804 2807 O
Part 19 23 2808 2812 O
2 24 25 2813 2814 O
, 25 26 2814 2815 O
Cohort 27 33 2816 2822 O
2 34 35 2823 2824 O
( 36 37 2825 2826 O
newly 37 42 2826 2831 O
diagnosed 43 52 2832 2841 O
AML 53 56 2842 2845 B-cancer
unfit 57 62 2846 2851 O
for 63 66 2852 2855 O
intensive 67 76 2856 2865 B-treatment
chemotherapy 77 89 2866 2878 I-treatment
) 89 90 2878 2879 O
The 91 94 2880 2883 O
following 95 104 2884 2893 O
criteria 105 113 2894 2902 O
should 114 120 2903 2909 O
be 121 123 2910 2912 O
met 124 127 2913 2916 O
by 128 130 2917 2919 O
participants 131 143 2920 2932 O
in 144 146 2933 2935 O
Dose 147 151 2936 2940 O
Expansion 152 161 2941 2950 O
Cohort 162 168 2951 2957 O
2 169 170 2958 2959 O
who 171 174 2960 2963 O
never 175 180 2964 2969 O
received 181 189 2970 2978 O
prior 190 195 2979 2984 B-treatment
treatment 196 205 2985 2994 I-treatment
for 206 209 2995 2998 O
AML 210 213 2999 3002 O
. 213 214 3002 3003 O
These 215 220 3004 3009 O
participants 221 233 3010 3022 O
need 234 238 3023 3027 O
not 239 242 3028 3031 O
meet 243 247 3032 3036 O
inclusion 248 257 3037 3046 O
criteria 258 266 3047 3055 O
1 267 268 3056 3057 O
and 269 272 3058 3061 O
2 273 274 3062 3063 O
( 275 276 3064 3065 O
above 276 281 3065 3070 O
) 281 282 3070 3071 O

Participant 0 11 3072 3083 O
is 12 14 3084 3086 O
ineligible 15 25 3087 3097 O
for 26 29 3098 3101 O
intensive 30 39 3102 3111 B-treatment
induction 40 49 3112 3121 I-treatment
chemotherapy 50 62 3122 3134 I-treatment
by 63 65 3135 3137 O
meeting 66 73 3138 3145 O
at 74 76 3146 3148 O
least 77 82 3149 3154 O
1 83 84 3155 3156 B-lower_bound
( 85 86 3157 3158 O
a 86 87 3158 3159 O
or 88 90 3160 3162 O
b 91 92 3163 3164 O
) 92 93 3164 3165 O
of 94 96 3166 3168 O
the 97 100 3169 3172 O
following 101 110 3173 3182 O
criteria 111 119 3183 3191 O

Participated 0 12 3192 3204 O
in 13 15 3205 3207 O
a 16 17 3208 3209 O
therapeutic 18 29 3210 3221 B-treatment
clinical 30 38 3222 3230 I-treatment
study 39 44 3231 3236 I-treatment
within 45 51 3237 3243 O
a 52 53 3244 3245 O
washout 54 61 3246 3253 O
time 62 66 3254 3258 O
of 67 69 3259 3261 O
2 70 71 3262 3263 O
weeks 72 77 3264 3269 O
or 78 80 3270 3272 O
5 81 82 3273 3274 O
half 83 87 3275 3279 O
- 87 88 3279 3280 O
lives 88 93 3280 3285 O
of 94 96 3286 3288 O
the 97 100 3289 3292 O
drug 101 105 3293 3297 O
/ 105 106 3297 3298 O
biologic 106 114 3298 3306 O
( 115 116 3307 3308 O
whichever 116 125 3308 3317 O
is 126 128 3318 3320 O
longer 129 135 3321 3327 O
) 135 136 3327 3328 O
before 137 143 3329 3335 O
starting 144 152 3336 3344 O
study 153 158 3345 3350 O
drug 159 163 3351 3355 B-treatment
treatment 164 173 3356 3365 I-treatment
under 174 179 3366 3371 O
this 180 184 3372 3376 O
protocol 185 193 3377 3385 O
, 193 194 3385 3386 O
or 195 197 3387 3389 O
current 198 205 3390 3397 O
participation 206 219 3398 3411 O
in 220 222 3412 3414 O
other 223 228 3415 3420 O
therapeutic 229 240 3421 3432 B-treatment
investigational 241 256 3433 3448 I-treatment
procedures 257 267 3449 3459 I-treatment

Prior 0 5 3460 3465 B-treatment
treatment 6 15 3466 3475 I-treatment
with 16 20 3476 3480 I-treatment
an 21 23 3481 3483 I-treatment
MDM2 24 28 3484 3488 I-treatment
inhibitor 29 38 3489 3498 I-treatment

pregnant 0 8 3499 3507 B-pregnancy

received 0 8 3508 3516 O
any 9 12 3517 3520 O
therapies 13 22 3521 3530 B-treatment
intended 23 31 3531 3539 O
to 32 34 3540 3542 O
treat 35 40 3543 3548 O
malignancy 41 51 3549 3559 B-cancer
within 52 58 3560 3566 O
14 59 61 3567 3569 B-upper_bound
days 62 66 3570 3574 I-upper_bound
of 67 69 3575 3577 O
first 70 75 3578 3583 O
receipt 76 83 3584 3591 O
of 84 86 3592 3594 O
DS-3032b 87 95 3595 3603 O
[ 96 97 3604 3605 O
except 97 103 3605 3611 O
for 104 107 3612 3615 O
hydroxyurea 108 119 3616 3627 B-treatment
, 119 120 3627 3628 O
which 121 126 3629 3634 O
must 127 131 3635 3639 O
be 132 134 3640 3642 O
discontinued 135 147 3643 3655 O
at 148 150 3656 3658 O
least 151 156 3659 3664 O
48 157 159 3665 3667 B-lower_bound
hours 160 165 3668 3673 I-lower_bound
( 166 167 3674 3675 I-lower_bound
Day 167 170 3675 3678 I-lower_bound
-2 171 173 3679 3681 I-lower_bound
) 173 174 3681 3682 I-lower_bound
prior 175 180 3683 3688 I-lower_bound
to 181 183 3689 3691 O
study 184 189 3692 3697 O
treatment 190 199 3698 3707 B-treatment
] 199 200 3707 3708 O

receiving 0 9 3709 3718 O
concomitant 10 21 3719 3730 O
treatment 22 31 3731 3740 B-treatment
with 32 36 3741 3745 I-treatment
a 37 38 3746 3747 I-treatment
strong 39 45 3748 3754 I-treatment
inhibitor 46 55 3755 3764 I-treatment
or 56 58 3765 3767 I-treatment
inducer 59 66 3768 3775 I-treatment
of 67 69 3776 3778 I-treatment
cytochrome 70 80 3779 3789 I-treatment
P450 81 85 3790 3794 I-treatment
3A4/5 86 91 3795 3800 I-treatment

